Quanlin An

机构：Sun Yat-sen University, Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0002-9725-6840

发表论文 16 篇 · 总被引 847 次 · h-index 9

代表论文

• Carbohydrate-based drugs launched during 2000−2021 (2022 · Acta Pharmaceutica Sinica B · 被引 261)
• Towards the overcoming of anticancer drug resistance mediated by p53 mutations (2019 · Drug Resistance Updates · 被引 183)
• Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors (2021 · The Innovation · 被引 159)
• Role of miR-221/222 in Tumor Development and the Underlying Mechanism (2019 · Journal of Oncology · 被引 90)
• Inhibition of cancer stem cell like cells by a synthetic retinoid (2018 · Nature Communications · 被引 76)
• Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway (2021 · Journal of Experimental & Clinical Cancer Research · 被引 20)